Nibec Co (138610.KQ) Stock Price

Nibec Co Ltd generates revenue through the sale of dental health products and regeneration biomaterials under its own brands. The dental health segment includes Blanc Tis for tooth whitening, SensBlok for sensitive teeth remedies, and Clinplant for dental conditioners. The regeneration biomaterials category features OCS-B, OCS-H, and OCS-Collagen for bone grafts, alongside bone regenerative powders, bone morphogenetic materials, and peptide bone powders. Additionally, the company sells cosmetics via the Skin Aropa brand. Domestic and overseas markets are the primary sales channels for all product lines. The company targets healthcare professionals and consumers seeking dental care solutions, with dental health products appealing to individuals managing oral hygiene needs. Regeneration biomaterials are directed at medical institutions requiring advanced bone healing solutions, while Skin Aropa cosmetics cater to personal care consumers. Nibec Co Ltd's product portfolio spans both B2B and B2C segments, with dental and biomaterials serving clinical and consumer markets. Nibec Co Ltd's revenue streams are derived from direct sales of its branded products. The dental health product line, including Blanc Tis, SensBlok, and Clinplant, serves both retail and professional markets. Regeneration biomaterials such as OCS-B, OCS-H, OCS-Collagen, and related products are sold to medical facilities for clinical use. Skin Aropa cosmetics are distributed to consumers through retail channels. All products are marketed under their respective brand names without third-party branding.